Dr. Parul Thakral

Dr. Parul Thakral

Senior Director
25 Years of Experience
Nuclear Medicine
Fortis Memorial Research Institute (FMRI), Gurgaon
BSc, MSc, PhD

English, Hindi

Get Free Evaluation

About Dr. Parul Thakral

  • Dr. Parul Thakral is a renowned Nuclear Medicine Expert in India, practicing for more than 24 years.
  • Her expertise includes conjugation & standardization of Radiolabeling and quality control of Ant-CD20 Monoclonal Antibody Rituximab with various radionuclides (90-Yttrium, 68-Gallium, 177-Lutetium).
  • She also has extensive experience with diverse Radionuclides & Radiopharmaceuticals.
  • She did her B.Sc. in Medical Technology (Radiography) in 2000 and an M.Sc. in Nuclear Medicine Technology in 2006 from All India Institute of Medical Sciences.
  • She also holds a Ph.D. in Radiochemistry & Clinical Nuclear Medicine from AIIMS, a renowned institute in Asia, in 2013.
  • Dr. Thakral is an active member of the World Association of Radiopharmaceutical & Molecular Therapy, the European Association of Nuclear Medicine (EANM), and the Society of Nuclear Medicine - India.

Awards of Dr. Parul Thakral

  • First prize in the 3rd International Medical Olympiad for Contribution in Radioimmunotherapy in Oncology.

Certificates of Dr. Parul Thakral

  • Assessment of Therapeutic Response to Yttrium-90 Radiolabelled Chimeric Anti-CD20 Antibody – Rituximab in patients of Relapsed and Refractory B-Cell Non-Hodgkin’s Lymphoma.
  • Study of Changes in Sleep Architecture, Melatonin Levels & Metabolic Abnormalities on F-18 Flurodeoxyglucose Positron Emission Tomography (FDG-PET) in person with Mild Cognitive Impairment (MCI) progressing to Alzheimer's Type Dementia (AD).

Paper Published by Dr. Parul Thakral

  • An approach for conjugation of 177Lu- DOTA-SCN- Rituximab (BioSim) and its evaluation for radioimmunotherapy of relapsed and refractory B-cell Non Hodgkins Lymphoma patients
  • Feasibility of 18F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure
  • Dosimetric analyses of Kidneys, Liver, Spleen, Pituitary gland and Neuroendocrine tumors of patients treated with 177Lu-DOTATATE
  • In-House Preparation and Quality Control of Ac-225 Prostate-Specific Membrane Antigen-617 for the Targeted Alpha Therapy of Castration-Resistant Prostate Carcinoma
  • Preliminary experience with Yttrium-90-labelled Rituximab (chimeric anti CD-20 antibody) in patients with relapsed and refractory B cell NHL
  • Radiation Dose to the Occupational Worker during the Synthesis of 188Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department
  • Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals
  • Charting the Course of Targeted ? Therapy With First-in-Human, Postadministration Image-Guided Dosimetry and Response Assessment of 212Pb-VMT-?-NET in Metastatic Neuroendocrine Tumors\
  • The Role of PET-CT-Guided Metabolic Biopsies in Improving Yield of Inconclusive Anatomical Biopsies: A Review of 5 Years in a Teaching Hospital
  • Validation of In-House Kit-Like Synthesis of 68Ga-Trivehexin and Its Biodistribution for Targeting the Integrin ?v?6 Expressing Tumors
  • Upfront Use of 177Lu-Labeled PSMA Radioligand Therapy and Treatment Response Assessment in Treatment-Naive Prostate Cancer
  • Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease
  • Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
  • Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer
  • In-House Preparation and Quality Control of Ac-225 Prostate-Specific Membrane Antigen-617 for the Targeted Alpha Therapy of Castration-Resistant Prostate Carcinoma
  • Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas
  • Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals
  • Dosimetric analysis of patients with gastro-entero-pancreatic neuro endocrine tumors (NETs) treated with PRCRT (Peptide Receptor Chemo Radionuclide Therapy) using Lu-177 DOTATATE and Capecitabine/Temozolamide (CAP/TEM)
  • Radiation Dose to the Occupational Worker during the Synthesis of Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department
  • Rare sites of metastases in prostate cancer detected on Ga-68 PSMA PET/CT scan-a case series

Experience of Dr. Parul Thakral

  • Senior Research Fellow, Department of Nuclear Medicine, AIIMS, New Delhi, 2016
  • RSO-II & Senior Nuclear Medicine Technologist, Sir Ganga Ram Hospital, 2009

Education of Dr. Parul Thakral

  • Bsc, All India Institute of Medical Sciences, New Delhi, 2000
  • MSc, All India Institute of Medical Sciences, New Delhi, 2006
  • PhD, ( Nuclear medicine) All India Institute of Medical Sciences, New Delhi,2013

Membership of Dr. Parul Thakral

  • World Association of Radiopharmaceutical & Molecular Therapy
  • European Association of Nuclear Medicine (EANM)
  • Society of Nuclear Medicine - India

Top Internal Medicine Doctors in India

Delivering Quality Care, Trusted Globally

View More
  • "My kidney transplant in India was a life-changing experience. The doctors and care I received were excellent, and I feel healthy again!"

    Mr. Abu

    Sierra Leone

  • "I traveled from Tajikistan for my oncology treatment, and the care I received was exceptional. The doctors were highly skilled, and the treatment gave me a new hope for life!"

    Patient from Tajikistan

  • "I came from Bangladesh for my heart bypass surgery, and the treatment I received was outstanding. The doctors and staff took great care of me, and I am now recovering well!"

    Patient from Bangladesh

  • "I traveled from Ghana for my heart palpitations treatment, and the care I received was excellent. The doctors were highly professional, and I feel much better now!"

    Mr. Mahama Toure

     Ghana

  • "I traveled from Nigeria for my kidney transplant, and the treatment I received was exceptional. The doctors were highly skilled, and I am now leading a healthier life!"

     Patient from Nigeria

  • "I traveled from Sudan for radiation oncology treatment, and the care I received was outstanding. The doctors were highly professional, and I am grateful for the excellent treatment!"

     Patient from Sudan

  • "I traveled from Congo for gastroenterology treatment, and the care I received was exceptional. The doctors were highly skilled, and I am feeling much better now!"

     Patient from Congo

  • "I traveled from Malawi for meniscus repair surgery, and the care I received was excellent. The doctors were highly professional, and I am now on my way to a smooth recovery!"

     Patient from Malawi

  • "I traveled from Iraq for my thyroidectomy, and the medical care I received was outstanding. The doctors were highly skilled, and I am now recovering well!"

     Patient from Iraq

  • "I traveled from Fiji for cataract surgery, and the treatment I received was excellent. The doctors were skilled, and my vision has improved significantly!"

    Patient from Fiji

  • "We traveled from Congo for an executive health check-up, and the medical care we received was excellent. The process was smooth, and the doctors provided thorough assessments!"

    Patients from Congo

  • "I traveled from Nigeria for neurology treatment, and the care I received was exceptional. The doctors were highly professional, and I am feeling much better now!"

    Patient from Nigeria

  • "I traveled from Fiji for oncology treatment, and the care I received was outstanding. The doctors were highly skilled, and I am grateful for the excellent treatment!"

    Patient from Fiji